#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Background information for Thanatophoric Dysplasia, Types 1 and 2 (FGFR3) 13 Mutations, Fetal Characteristics: Micromelia, macrocephaly, short ribs and a narrow thorax; TD I has bowed femurs and TD II has straight femurs and a cloverleaf skull; death usually occurs from respiratory insufficiency within hours or days of birth. Incidence: 1 in 20,000 to 50,000 births. Inheritance: Autosomal dominant; arising from a de novo mutation. Cause: Fibroblast growth factor receptor 3 (FGFR3) gene mutations. Mutations tested: c.742C>T (R248C), c.746C>G (S249C), c.1108G>T (G370C), c.1111A>T (S371C), c.1118A>G (Y373C), c.2419T>G (X807G), c.2419T>A (X807R), c.2420G>T (X807L), c.2420G>C (X807S), c.2421A>T (X807C), c.2421A>C (X807C) and c.2421A>G (X807W) for TD I and c.1948A>G (K650E) for TD II. Clinical Sensitivity and Specificity: 99 percent. Methodology: Polymerase chain reaction (PCR) and single nucleotide extension followed by capillary electrophoresis. Analytic Specificity and Sensitivity: 99 percent. Limitations: Mutations other than those targeted in FGFR3 will not be detected; analytic sensitivity may be compromised by rare primer site mutations.
For quality assurance purposes, ARUP Laboratories will confirm the above result at no charge following delivery. Order Confirmation of Fetal Testing and include a copy of the original fetal report (or the mother's name and date of birth) with the test submission. Please contact an ARUP genetic counselor at (800) 242-2787 extension 2141 prior to specimen submission.
This test is performed pursuant to an agreement with Roche Molecular Systems, Inc.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.
See Compliance Statement C: www.aruplab.com/CS
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
81479; Fetal Cell Contamination (FCC): 81265
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
TD (Thanatophoric Dysplasia, Types 1 & 2 (FGFR3) 13 Mutations, Fetal)
|
*ExistCrossReferences>
|